Insiders · Profile

Adda Nathalie

Sr. VP & Chief Medical Officer at ENANTA PHARMACEUTICALS. Filing since 16 Apr 2018. CIK 0001646976

Company
Date
Role
Action
Shares
Amount
Of holding
4 Apr 2022
Sr. VP & Chief Medical Officer
Sold, plan not stated
32,785
$2.37M
48.4%
1 Apr 2022
Sr. VP & Chief Medical Officer
Sold, plan not stated
50,559
$3.60M
59.1%
2 Mar 2022
Sr. VP & Chief Medical Officer
Sold, plan not stated
12,481
$874.54K
26.3%
1 Mar 2022
Sr. VP & Chief Medical Officer
Sold, plan not stated
24,339
$1.71M
41.0%
11 Jan 2022
Sr. VP & Chief Medical Officer
Sold, plan not stated
12,536
$879.15K
27.6%
1 Dec 2021
Sr. VP & Chief Medical Officer
Sold, plan not stated
13,523
$1.17M
29.1%
1 Nov 2021
Sr. VP & Chief Medical Officer
Sold, plan not stated
9,547
$810.42K
26.2%
11 Oct 2021
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,047
$284.69K
13.1%
8 Oct 2021
Sr. VP & Chief Medical Officer
Sold, plan not stated
13,453
$942.93K
33.3%
20 Sep 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,155
$396.04K
100%
20 Aug 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,155
$383.60K
93.1%
18 Jul 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
5,045
$629.84K
77.0%
18 Jun 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,155
$477.22K
53.6%
16 May 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,155
$437.33K
46.4%
16 Apr 2018
Sr. VP & Chief Medical Officer
Sold, plan not stated
4,225
$361.56K
41.3%
15 decisions on file.